in tumor-bearing KPC mice up-regulated MHC class II and the costimulatory molecule CD86 with expression levels peaking at day 3 and returning to baseline after 7 days (Fig. 3H , and figs. S13 and S14). These changes coincided with a cytokine surge on day 1 after FGK45 treatment, with elevated serum levels of IL-12, TNF-a, and IFN-g, but not IL-10, in KPC animals ( fig. S15 ).
To determine whether macrophages were necessary for CD40-mediated tumor regression, we depleted systemic macrophages from KPC mice with CELs. Treatment with CELs abolished the capacity of FGK45 to induce tumor regression (Fig. 4A) . Macrophages isolated from the pancreas of tumor-bearing KPC animals treated in vivo with FGK45 lysed tumor cells in vitro (Fig. 4B ). This finding correlated with in vivo observations of cleaved caspase 3 expression in focal areas of the tumor at 18 hours after treatment with FGK45 ( Fig. 4C) . At this time after treatment, regions of the tumor stroma and associated fibrosis appeared to be undergoing involution (Fig. 4 , D to G). These regions displayed a decrease in collagen I content, consistent with degradation of the tumor matrix (Fig.  4 , H and I). In KPC mice depleted of systemic macrophages using CELs, FGK45 treatment failed to induce stromal degradation (Fig. 4 , J to L). These findings identify a novel mechanism whereby the CD40 pathway can be harnessed therapeutically to restore tumor immune surveillance by targeting tumor-infiltrating macrophages involved in cancer inflammation.
PDA is a common, devastating, and highly lethal tumor for which new therapies are critically needed. Our findings identify a previously unappreciated role for the CD40 pathway in regulating the immune reaction and fibrosis associated with PDA by reeducation of tumorassociated macrophages. Mechanistically, CD40 agonists altered tumor stroma and, in both mice and humans, showed efficacy against PDA. Although tumor-suppressing macrophages have been previously described (22) , their role has been largely linked to the orchestration of T cell antitumor immunity. In this study, CD40 activation was, by itself, insufficient for invoking productive antitumor T cell immunity, and we hypothesize that full engagement of T cell immunity in PDA after CD40 activation will require modulation of additional tumor and host factors or the incorporation of novel vaccines (23) . Our results emphasize that tumor immunosurveillance can at times be governed strictly by innate immunity under the regulation of the CD40 pathway and support the continued development of emerging therapeutic strategies that target inflammatory cells and stroma within the tumor microenvironment. adjacent to the midbody. The first microtubule bundle disassembly occurred 49 T 10 min after complete furrow ingression, followed by disassembly of the second bundle~20 min later. In an abscission timing assay based on cytoplasmic exchange of photoactivatable GFP (PAGFP) between the two sister cells (9) , the complete disassembly of the first microtubule bundle coincided with abscission in most cells (45 of 51 within a 5-min sampling time; Fig. 1, C to E) .
To observe abscission, we imaged live cells until partial disassembly of microtubules at the intercellular bridge occurred, and then we chemically fixed cells for serial thin-section electron microscopy. At all sites of partial microtubule disassembly (n = 9), the cortex of the intercellular bridge had ingressed to a narrow stalk, which contained a tightly compressed bundle of microtubules (constriction zone in Fig. 1, F and G, and fig. S1 ). The constriction site cortex was deformed by regularly spaced electron-dense ripples (Fig. 1G) , a previously observed structural feature of intercellular bridges (10) . Ripples were absent in earlier stages (n = 5 cells fixed <40 min after furrow ingression; fig. S2 ). The constriction zone localized 0.95 T 0.41 mm (n = 19) from the center of the midbody. Postabscission midbody remnants contained cytoplasmic regions of matching size ( fig. S3 ), indicating that the constriction zone is the site of abscission. Thus, assembly of a specialized cortical structure in late-stage intercellular bridges mediates abscission by cortical constriction adjacent to the midbody.
We did not detect vesicles at constriction zones (Fig. 1, F and G, and fig. S1 ). Live-cell imaging of the secretory vesicle marker EGFP-Rab8 (11) showed that Golgi-derived vesicles gradually disappeared from the intercellular bridge long before abscission (Fig. 2, A and B) . Disruption of the Golgi apparatus using brefeldin A (12) prevented EGFP-Rab8 targeting to the intercellular bridge ( fig. S4 ) but did not perturb abscission (Fig. 2C) . Thus, abscission proceeds by www.sciencemag.org SCIENCE VOL 331 25 MARCH 2011 a cortical ingression mechanism independent of Golgi-derived secretion.
Cortical constriction requires removal of underlying microtubules. As reported (13, 14) , RNA interference (RNAi) depletion of the microtubule-severing enzyme spastin delayed abscission ( Fig. 2D and fig. S5 , A to C). However, spastin-depleted cells still contained constriction zones with electron-dense ripples ( Fig. 2E ; n = 7). To test indirect consequences of perturbed microtubule homeostasis in spastin-depleted cells, we added the microtubule-depolymerizing compound T138067 (15) after furrow ingression. This led to efficient suppression of the spastin RNAiinduced abscission delay (Fig. 2D) . Thus, microtubules are not required for abscission once the intercellular bridge has formed, and their spastinmediated disassembly is a rate-limiting step of abscission.
Super-resolution imaging with three-dimensional structured illumination microscopy (16 ) revealed that F-actin, a candidate factor for cortical constriction, accumulated adjacent to early-stage midbodies (Fig. 2F and fig. S6A ). At later stages, however, F-actin localized only to distal ends of the intercellular bridge, and it was undetectable at constriction sites in 12 out of 14 cells (Fig. 2G  and fig. S6B ). Depolymerization of F-actin by latrunculin B added after furrow ingression had no effect on abscission (Fig. 2C) . Thus, F-actin is unlikely to contribute to cortical constriction during abscission.
Endosomal sorting complex required for transport III (ESCRT-III) is an attractive candidate cortical constriction factor, with known membranedeforming activity in reconstituted vesicle budding (17) (18) (19) . ESCRT-III is required for abscission, and it localizes within intercellular bridges (20, 21) . We observed the EGFP-tagged CHMP4B core ESCRT-III subunit, stably expressed from an endogenous promotor, to be at very low levels within early-stage intercellular bridges. Then its levels increased dramatically until disassembly of the first midbody-associated microtubule bundle (Fig. 3, A and B, and fig. S7, A and B) . CHMP4B localized to two narrow cortical rings adjacent to the midbody before microtubule disassembly ( Fig. 3C; 13 of 15) . Upon microtubule disassembly, CHMP4B and other ESCRT-III core subunits extended toward the constriction site (six of six; Fig. 3D and figs. S7 and S8) . Thus, ESCRT-III accumulates in late-stage intercellular bridges as a component of cortical constriction zones.
To test ESCRT-III function in cortical constriction, we used RNAi to deplete the CHMP2A core subunit (fig. S5, D and E) , and we performed correlative live-cell and electron microscopy. Early midbodies (<40 min after furrow ingression) of CHMP2A-depleted cells had normal morphology ( fig. S5F ). However, late-stage intercellular bridges (>40 min after furrow ingression) were always devoid of rippled constric- tion zones (Fig. 3E; n = 16) . Thus, ESCRT-III is required for cortical constriction.
Microtubule depolymerization by T138067 when added after furrow ingression did not restore abscission in CHMP2A-depleted cells (Fig. 3F) . Thus, microtubule disassembly is not sufficient to split the intercellular bridge, suggesting a direct function of ESCRT-III in abscission, in addition to its known requirement for spastin targeting (14) .
ESCRT-III-mediated cortical constriction needs coordination with microtubule disassembly. Consistent with this, spastin was 8.7 T 0.9 times more abundant on the side of the midbody that disassembled microtubule bundles (Fig. 3, G and H;  n = 16 ). This supports a model of spatially and temporally coordinated ESCRT-III-driven cortical constriction and spastin-mediated microtubule disassembly.
ESCRT-III targeting to the intercellular bridge depends on centrosome protein 55 (CEP55) and the ESCRT-related protein ALIX (21-23). We found that both EGFP-tagged ALIX (Fig. 3I, 19  of 22) and CEP55 (fig. S8, G and H; 25 of 25) were confined to the midbody, whereas ESCRT-III was excluded from internal midbody regions (Fig. 3, C and D) . CEP55 accumulated at the midbody earlier than CHMP4B and ALIX (Fig. 3B  and fig. S8, I and J). This indicates a mechanism of sequential targeting to the midbody periphery underlying the assembly of ESCRT-III constriction zones.
We next performed electron tomography of high-pressure frozen HeLa cells at the abscission stage. The constriction site contained cortical filaments oriented perpendicular to the underlying microtubules (Fig. 4, A to F) . These filaments were 17.3 T 2.5 nm (mean T SD; n = 60 measurements at five constriction zones) wide and regularly spaced at 35.3 T 4.1 nm distances. The cortical filaments formed single or intertwined helices spanning the intercellular bridge (Fig. 4F   and fig. S9 ; n = 4 constriction zones). Thus, a helical filament system may generate contractile force to narrow the membrane tube of the intercellular bridge.
Because of the known polymerization and membrane-deforming activity of ESCRT-III (17, (24) (25) (26) (27) and because of our observed colocalization of ESCRT-III with constriction zones, we speculate that the 17-nm-diameter filaments may be composed of polymerized ESCRT-III core components. Supporting this idea, the 17-nm-diameter filaments did not occur in intercellular bridges of high-pressure frozen CHMP2A RNAi cells (n = 7 late-stage intercellular bridges; fig. S10 ). In contrast, spastin RNAi did not perturb 17-nm filaments ( fig. S11) .
Our study reveals a cortical constriction mechanism of abscission involving ESCRT-III-dependent membrane deformation and spastin-mediated microtubule disassembly ( fig. S12) . Vesicles, microtubules, and F-actin are not directly required for abscission in HeLa cells, yet our data do not exclude the possibility that they function in preparatory steps. Our data are consistent with a model in which ESCRT-III mediates membrane tube constriction as filament helices spanning the~1-mm-wide intercellular bridge. Possible forcegenerating mechanisms could emerge during assembly of filaments from inward-directed filament curvature, from lateral skew of sliding helices, or from gradual removal of monomers from filaments.
